稀疏采样CT(SpSCT)用于肺栓塞检测的可行性研究
本研究利用20例临床患者的CT肺动脉造影数据,模拟6个剂量水平及全采样、每二投影和每四投影稀疏采样重建,由4名盲法放射科医师评估。稀疏采样在各剂量水平下敏感度、特异度、准确率和曲线下面积均高于全采样,仅每四投影稀疏采样在12.5%剂量水平下所有检查均达诊断图像质量。结论认为稀疏采样CT可将CTPA剂量降至12.5%剂量水平(平均有效剂量0.38 mSv)而保持高图像质量和完整诊断信心。
要点
- 每二投影和每四投影稀疏采样在25%和12.5%剂量水平下肺栓塞各部位敏感度均为100%(一个亚组为98.5%)。
- 全采样在12.5%剂量水平下敏感度降至90%,稀疏采样在各剂量水平下敏感度、特异度、准确率和曲线下面积均高于全采样。
- 仅每四投影稀疏采样在12.5%剂量水平下所有检查均被评为具有诊断图像质量。
核心结论
- 通过稀疏采样CT,CTPA剂量可降至12.5%剂量水平(本研究中对应平均有效剂量0.38 mSv),同时保持高图像质量和完整诊断信心。
研究设计与样本
- 可行性研究,使用20例临床患者的CT肺动脉造影扫描数据,模拟低剂量扫描(临床剂量的100%、50%、25%、12.5%、6.3%、3.1%,共6个剂量水平),从全采样数据中每隔一个(每二投影稀疏采样)或每隔三个(每四投影稀疏采样)投影获取模拟稀疏采样扫描,由4名盲法放射科医师评估主观图像标准(伪影、图像质量)和诊断性能(信心、敏感度、特异度、准确率、曲线下面积),并评估对比噪声比作为客观图像质量指标。
诊断标准与关键数值
- 每二投影和每四投影稀疏采样在25%剂量水平和12.5%剂量水平下,肺栓塞各部位敏感度均为100%(一个亚组为98.5%)。
- 全采样在12.5%剂量水平下敏感度降至90%。
- 每二投影和每四投影稀疏采样在所有剂量水平下敏感度、特异度、准确率和曲线下面积均高于全采样。
- 每四投影稀疏采样在每个剂量水平下主观图像质量均显著高于全采样(p < 0.01,配对t检验)。
- 仅每四投影稀疏采样在12.5%剂量水平下所有检查均被评为具有诊断图像质量。
临床应用与阅片要点
- 本研究表明稀疏采样CT在模拟条件下可在12.5%剂量水平(平均有效剂量0.38 mSv)维持高图像质量和完整诊断信心,作者结论认为该剂量降低是可能的。
- 阅片时需注意稀疏采样为一种硬件方案,通过采集更少投影图像实现剂量降低,与常规全采样重建图像不同。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Evaluation of sparse sampling computed tomography (SpSCT) regarding subjective and objective image criteria for the detection of pulmonary embolism (PE) at different simulated dose levels.
METHODS: Computed tomography pulmonary angiography (CTPA) scans of 20 clinical patients were used to obtain simulated low-dose scans with 100%-50%-25%-12.5%-6.3%-3.1% of the clinical dose, resulting in a total of six dose levels (DL). From these full sampling (FS) data, every second (2-SpSCT) or fourth (4-SpSCT) projection was used to obtain simulated sparse sampling scans. Each image set was evaluated by four blinded radiologists regarding subjective image criteria (artifacts, image quality) and diagnostic performance (confidence, sensitivity, specificity, accuracy, and area under the curve). Additionally, the contrast-to-noise ratio (CNR) was evaluated for objective image quality.
RESULTS: Sensitivity was 100% with 2-SpSCT and 4-SpSCT at the 25% DL and the 12.5% DL for all localizations of PE (one subgroup 98.5%). With FS, the sensitivity decreased to 90% at the 12.5% DL. 2-SpSCT and 4-SpSCT showed higher values for sensitivity, specificity, accuracy, and the area under the curve at all DL compared with FS. Subjective image quality was significantly higher for 4-SpSCT compared with FS at each dose level (p < 0.01, paired t test). Only with 4-SpSCT, all examinations were rated as showing diagnostic image quality at the 12.5% DL.
CONCLUSIONS: Via SpSCT, a dose reduction down to a 12.5% dose level (corresponding to a mean effective dose of 0.38 mSv in the current study) for CTPA is possible while maintaining high image quality and full diagnostic confidence.
KEY POINTS: • With sparse sampling CT, radiation dose could be significantly reduced in clinical routine. • Sparse sampling CT is a novel hardware solution with which less projection images are acquired. • In the current study, a dose reduction of 87.5% (corresponding to a mean effective dose of 0.38 mSv) for CTPA could be achieved while maintaining excellent diagnostic performance.
引用
- Sauter AP, Kopp FK, Bippus R, et al. Sparse sampling computed tomography (SpSCT) for detection of pulmonary embolism: a feasibility study. Eur Radiol. 2019. PMID: 31073861. doi:10.1007/s00330-019-06217-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。